Harvard Bioscience Inc SEC filings HBIO

Harvard Bioscience Inc has 1,000 filings in SEC EDGAR's recent list, going back to Nov 20, 2007. Its latest annual report, Form 10-K, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
S-8 Employee stock plan registration Jun 10, 2026 —
424B3 Prospectus Feb 9, 2026 —
S-3 Shelf registration Jan 30, 2026 —
S-3 Shelf registration Dec 6, 2024 —
S-8 Employee stock plan registration Jun 8, 2022 —
S-8 Employee stock plan registration May 19, 2021 —
S-8 Employee stock plan registration Nov 6, 2020 —
S-8 Employee stock plan registration May 30, 2019 —
S-8 Employee stock plan registration Jun 1, 2018 —
S-3 Shelf registration Apr 30, 2018 —
S-8 Employee stock plan registration Jun 5, 2017 —
S-8 Employee stock plan registration Jun 5, 2015 —
S-3/A Form s-3/a Apr 27, 2015 —
S-3 Shelf registration Apr 21, 2015 —
S-8 Employee stock plan registration Jun 7, 2013 —
S-8 Employee stock plan registration May 25, 2011 —
S-8 Employee stock plan registration May 19, 2008 —

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Laboratory Analytical Instruments (SIC 3826)
Listed as
HBIO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Holliston, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1123494

Other Laboratory Analytical Instruments companies

All 25 Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.